Добірка наукової літератури з теми "Os – Infections – Thérapeutique"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Os – Infections – Thérapeutique".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Os – Infections – Thérapeutique":
Batard, Eric, and Gilles Potel. "Thérapeutique des infections à staphylocoques." EMC - Maladies infectieuses 3, no. 4 (January 2006): 1–8. http://dx.doi.org/10.1016/s1166-8598(06)41682-3.
Mootien, J. Y., and J. R. Zahar. "Entérobactéries productrices de carbapénémases en médecine intensive : thérapeutique." Médecine Intensive Réanimation 27, no. 4 (July 2018): 372–80. http://dx.doi.org/10.3166/rea-2018-0058.
Valade, S., E. Canet, and E. Mariotte. "Syndrome d’activation macrophagique d’origine infectieuse : le point de vue du réanimateur." Médecine Intensive Réanimation 27, no. 3 (May 2018): 239–48. http://dx.doi.org/10.3166/rea-2018-0048.
Chanal, Johan, François Lassau, Philippe Morand, Michel Janier, and Nicolas Dupin. "Actualités diagnostique et thérapeutique des infections à Neisseria gonorrhoeae." La Presse Médicale 42, no. 4 (April 2013): 454–58. http://dx.doi.org/10.1016/j.lpm.2012.09.023.
Castelain, V., G. Morel, M. P. Ledoux, and R. Herbrecht. "Prise en charge des infections invasives à champignons filamenteux en réanimation : quel(s) antifongique(s) utiliser ?" Médecine Intensive Réanimation 29, no. 1 (March 1, 2020): 24–31. http://dx.doi.org/10.37051/mir-00005.
Gerber, V., B. Dimitrov, V. Greigert, M. Mohseni, G. M. Pelami, P. David, P. Keller, and M. Martinot. "Analyse clinique, microbiologique et thérapeutique des infections de prothèse abdominale." Médecine et Maladies Infectieuses 48, no. 4 (June 2018): S84—S85. http://dx.doi.org/10.1016/j.medmal.2018.04.211.
Harf-Monteil, C., J. Gaudias, J. Loichot, and H. Monteil. "Infections de plaies à Aeromonas : un piège diagnostique et thérapeutique." Médecine et Maladies Infectieuses 33, no. 11 (November 2003): 590–92. http://dx.doi.org/10.1016/s0399-077x(03)00003-9.
Mongardon, N., and A. Cariou. "Hypothermie thérapeutique après arrêt cardiaque et infections acquises en réanimation." Réanimation 24, no. 3 (March 23, 2015): 224–35. http://dx.doi.org/10.1007/s13546-015-1045-7.
KERDOUN, Mohamed Amine, Hadjer BALLOUTI, Yasmine GUERGOUR, Hanane GUELALTA, Assia YAMOUN, Sabah BENBOUDIAF, and Faiza BOUCHALA. "Demonstration of inter and intraindividual pharmacokinetic variability during gentamicin treatment in hospitals." Batna Journal of Medical Sciences (BJMS) 5, no. 1 (December 25, 2018): 53–56. http://dx.doi.org/10.48087/bjmsoa.2018.5113.
BARRÉ, M., J. MORIN, A. VALOIS, H. LEHOT, J. E. BLATTEAU, and J. J. MORAND. "Mise au point sur l’utilisation de l’oxygénothérapie hyperbare en dermatologie." Médecine et Armées Vol.49 No.4, Volume 49, Numéro 4 (December 20, 2023): 99–112. http://dx.doi.org/10.17184/eac.8054.
Дисертації з теми "Os – Infections – Thérapeutique":
Nivoix, Yasmine. "Infections fongiques invasives : épidémiologie et optimisation thérapeutique." Strasbourg, 2009. http://www.theses.fr/2009STRA2006.
Nahum, Joseph. "Thérapeutique des infections à Herpes simplex virus." Paris 5, 1999. http://www.theses.fr/1999PA05P200.
Berthelot, Philippe. "Exploration endoscopique et instrumentation thérapeutique comme sources d'infection respiratoire nosocomiale." Saint-Etienne, 1993. http://www.theses.fr/1993STET6411.
Wolf-Lissorgue, Marie-France. "Enquête de prévalence instantanée concernant l'infection et la thérapeutique anti-infectieuse à l'hôpital Broussais." Paris 5, 1993. http://www.theses.fr/1993PA05P091.
Delaunay, Isabelle. "La mucoviscidose : complications infectieuses pulmonaires : stratégies thérapeutiques médicale et chirurgicale, à propos de 4 observations d'adultes jeunes." Caen, 1990. http://www.theses.fr/1990CAEN3097.
Gauchet, Aurélie. "Les déterminants psychosociaux de l'observance thérapeutique chez les personnes infectées par le VIH : représentations et valeurs." Metz, 2005. http://docnum.univ-lorraine.fr/public/UPV-M/Theses/2005/Gauchet.Aurelie.LMZ0501_1.pdf.
In 1996 with the apparition of tritherapy, patients have to learn to live with their HIV and so with a chronic illness. Many publications have shown the importance of compliance (respect of medical prescription) with HIV patients. This study intends showing to which extent the compliance is influence by social and psychological variables significant. This research executed in 2002, gathered 127 HIV patients (aged from 18-65 years) which have filled up a questionnaire at the occasion of their quaterly consultation at the Metz Hospital (France). The subjects had to answer a French Compliance Scale (Tarquinio, Fisher Grégoire, 2000), the Illness Perception Questionnaire (IPQ, Weinman), the Belief Medical Questionnaire (BMQ, Horne), a French Value System Scale (Fischer), a treatment satisfaction scale and sociodemographic variables. We made multidimensional analyses (PCA : Principal Component Analysis ; Multiple Regression Analysis, and Structural Equation), in order to show the principal variables subjacent to scales. Results reveal that the social and psychological variables significant as patients'believes, their values, environmental factors and physician-patient relation, influence compliance. The principal variables which affect compliance are patients' believes about treatment, satisfaction about treatment, confidence beside the physician, social support, duration of treatment and illness, and truthful communication. The results of this study will give to the physicians the possibility to adjust their advices and the treatments in taking into account those social and psychological variables significant, in order to increase the compliance of HIV patients
Fontanet, Isabelle. "L'infection materno-fœtale : approche épidémiologique des unités de pathologie néonatale du Centre Hospitalier Régional de Bordeaux, approche thérapeutique (1992-1995)." Bordeaux 2, 1996. http://www.theses.fr/1996BOR23032.
Bonal-Saade, Catherine. "Infections congénitales à cytomégalovirus traitées par ganciclovir : à propos de deux observations." Montpellier 1, 1995. http://www.theses.fr/1995MON11067.
Zupanc, Kauss Tina. "Intérêt thérapeutique et formulation galénique des polyphénols dans le traitement des infections et inflammations." Bordeaux 2, 2007. http://www.theses.fr/2007BOR21501.
Immune response can become a pathological process, leading to a joint matrix destruction in rheumatoid arthritis or to a chronic cachexia in African trypanosomosis. In both pathologies, new therapeutics are needed for a better patients care. Flavonols, non toxic vegetal compounds, could bring a therapeutic alternative in these diseases, but their anti-inflammatory and anti-parasitic effects should be proved and/or characterized. We evaluated therefore the therapeutic potential of two flavonols, quercetin and rutin, in view of their use in human medicine. The effects of non toxic doses of flavonols on macrophage inflammatory mediators' gene transcription and protein expression were studied. In vitro inhibition of TNFα? il1β and NO was also confirmed on rat adjuvant-induced arthritis model, showing a correlation between clinical signs of inflammation (clinical scores and cachexia) and serum inflammatory mediators. In addition, quercetin and rutin trypanocidal effects were demonstrated and the kinetics and dose-response relationship studied. Furthermore, the in vitro trypanocydal effect of vitamin C was highlighted. In vivo studies should confirm the effectiveness of these molecules in African trupanosomosis. A first galenic approach was also conducted in order to improve the bioavailability and consequent therapeutic effects of flavonols
Desrosiers, Vincent. "Nouvelle avenue thérapeutique pour traiter une infection par le VIH-1." Master's thesis, Université Laval, 2018. http://hdl.handle.net/20.500.11794/31388.
Macrophages plays an important role in HIV-1 infection. These cells are suspected to act as a viral reservoir preventing complete virus eradication in infected individuals. Following a transcriptomic study, fifty genes were selected based upon their differential expression between non-infected, infected and bystander populations. One of those genes, coding for Gamma-Glutamyl Hydrolase (GGH), an enzyme involved in folate metabolism, was upregulated rapidly after HIV-1 infection before returning to a basal state. We propose that in monocyte-derived macrophages (MDM), a low folate concentration may play a protective role by limiting nucleotide availability for HIV-1 during the process of infection. We have developed an experimental model based on MDM identification productively infected with a R5 tropism HIV-1 molecular clone expressing all viral genes and a small membrane murine protein (Heat Stable Antigen; HSA). This virus was used to infect MDM transfected with small interfering RNAs (siRNA) or exposed to chemical inhibitors. The purpose of those experiments was to assess the effect of genetic downregulation of important folate proteins during HIV-1 infection. Between 3 and 18 days post-infection, percentage of productively infected cells was evaluated with flow cytometry or ELISA targeting the viral capsid protein p24. Downregulation of important enzymes involved in intracellular folate retention (e.g. GGH, FPGS and MTHFR) increased the number of cells productively infected with HIV-1. Also, Raltitrexed (RTX), a specific inhibitor of Tymidylate Synthase (TYMS), was able to inhibit viral replication when used before infection. Those results show that an interplay between HIV-1 and folate cycle may play a decisive role in MDM susceptibility to virus infection.
Книги з теми "Os – Infections – Thérapeutique":
Dariosecq, Jean-Michel. Infection VIH: Mémento thérapeutique 2003. 6th ed. Rueil-Malmaison: Doin, 2003.
Malago, Joshua J. Probiotic Bacteria and Enteric Infections: Cytoprotection by Probiotic Bacteria. Dordrecht: Springer Science+Business Media B.V., 2011.
Powderly, William G. Manual of HIV therapeutics. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2001.
Moss, Adrian. HIV and AIDS: Management by the primary care team. Oxford: Oxford University Press, 1992.
Catalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.
Catalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.
Michael, Moore. Herbs for the urinary tract: Herbal relief for kidney stones, bladder infections, and other problems of the urinary tract. New Canaan, Conn: Keats Publishing, 1998.
International Conference on Endotoxins Amsterdam (3rd 1990). Bacterial endotoxins: Cytokine mediators and new therapies for sepsis : proceedings of the Third International Conference on Endotoxins, held in Amsterdam, the Netherlands, June 7-8, 1990. Edited by Sturk Auguste, International Endotoxin Society, European Shock Society, and European Conference on Intensive Care Medicine (5th : 1990 : Amsterdam, Netherlands). New York: Wiley-Liss, 1991.
Kaiser, Jon D. Healing HIV: How to rebuild your immune system. Mill Valley, Calif: HealthFirst Press, 1999.
Finley, Bryce. Echinacea: How to grow, harvest, and use this amazing flower to fight colds, flu, and infection by boosting your immune system. Christina Lake, B.C., Canada: B. Finley, 1994.
Частини книг з теми "Os – Infections – Thérapeutique":
Klastersky, J., and M. Aoun. "Prévention et traitement des infections." In Thérapeutique du cancer, 151–65. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-8178-0021-9_10.
Navas, Dominique, Jean-François Huon, and Stéphane Ploteau. "Traitement des infections gynécologiques." In Pharmacie Clinique et Thérapeutique, 815–24. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-75077-9.00045-1.
Kaiser, Jean-Daniel, Joël Leroy, and Samuel Limat. "Traitement des infections osseuses." In Pharmacie Clinique et Thérapeutique, 825–32. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-75077-9.00046-3.
Kaiser, Jean-Daniel, Joël Leroy, and Samuel Limat. "Traitement des infections digestives." In Pharmacie Clinique et Thérapeutique, 843–52. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-75077-9.00048-7.
Ferreira, Ema, and Natacha Chaumard. "Traitement des infections gynécologiques." In Pharmacie clinique et thérapeutique, 993–1003. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50049-1.
Singlas, Éric, and Nicole Desplaces. "Traitement des infections osseuses." In Pharmacie clinique et thérapeutique, 1005–14. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50050-8.
Steinmetz, Jean-Philippe, Marie-Odile Decroix†, Jean-Philippe Steinmetz, and Matthieu Roustit. "Traitement des infections digestives." In Pharmacie clinique et thérapeutique, 1029–40. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50052-1.
Barrail-Tran, Aurélie. "Traitement des infections urinaires bactériennes." In Pharmacie Clinique et Thérapeutique, 791–800. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-75077-9.00043-8.
Raignoux, Cécile, Robert Farinotti, Robert Farinotti, François Gimenez†, and Anne-Claude Crémieux. "Traitement des infections urinaires bactériennes." In Pharmacie clinique et thérapeutique, 959–69. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50046-6.
Armoiry, Xavier, Xavier Dode, Gilles Aulagner, François Gimenez†, Bruno Crestani, and Sophie Raymond. "Traitement des infections respiratoires basses bactériennes." In Pharmacie clinique et thérapeutique, 971–80. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50047-8.
Тези доповідей конференцій з теми "Os – Infections – Thérapeutique":
Oujdad, S., S. Zafad, H. El Attar, and I. Ben Yahya. "Histiocytose langerhansienne de l’adulte : à propos d’un cas." In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206603013.